ORTEXORTEX News
Tracking STT? Get live short interest, options flow, and signals on ORTEX.Sign up free →
ST
Trader NoteSTT

State Street Short Interest Hits Year High as Analysts Cut Targets

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 31 Oct 2026, 20:25

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Short sellers have been rebuilding positions in STT at an unusually fast pace, pushing short interest to its highest level in at least a year.

Shares short rose 21% over the past week to roughly 6.3 million, equivalent to 2.3% of the free float. Over the past month, the position has grown by nearly 48%. This week's move was about 1.7 standard deviations above the typical weekly shift in short interest for State Street, making it a statistically notable acceleration rather than routine noise. FINRA's most recent fortnightly settlement confirms the direction: officially reported shorts stood at 6.2 million shares as of mid-October, with days to cover at 2.5.

Despite the build in short positions, the borrow market tells a loose story. Availability is at roughly 9,374%, meaning shares remain extremely easy to source relative to the amount already lent out. Cost to borrow is 0.45%, well below any level that would pressure short sellers financially. The ORTEX short score has ticked up through the week, reaching 33.7, but that still places STT in the middle of the universe by short-score rank. Options positioning is similarly calm: the put/call ratio at 0.86 sits just below its 20-day average of 0.88, with a z-score of negative one. There is no unusual demand for downside protection in the options market, which puts the short-side accumulation in context.

The analyst community has been broadly cutting targets since State Street reported third-quarter results on October 14, when the stock fell 3.7% on the day and extended that loss to about 3% over the following week. Target reductions came from BMO Capital, Citigroup, RBC Capital, Truist Securities, and Evercore ISI, all maintaining ratings while trimming price objectives by amounts ranging from $11 to $22. The sole outlier was Keefe, Bruyette and Woods, which raised its target to $230. Most recently, JP Morgan's Vivek Juneja raised his target from $187.50 to $192.50 while keeping a Neutral rating, a modest upward revision that still sits well above the current price of $169.77. The consensus remains Hold, with six holds and one underperform. The Street's bull case centres on record assets under custody of $59.2 trillion, a 25.1% return on tangible common equity, and raised full-year guidance. Bears point to fee revenue that missed estimates, with servicing, FX, and other fee lines all falling short of expectations, and earnings that remain sensitive to equity market levels.

Valuation multiples have been broadly stable. The forward PE has moved little over the past 30 days, while the price-to-book ratio of 1.77 has edged up slightly over the same period. Factor scores show STT ranks in the 92nd percentile on analyst recommendation divergence and the 99th percentile on dividend score, though the 12-month forward EPS year-on-year increase ranks at just the 36th percentile. Insider activity over the past 90 days runs modestly negative: net open-market sales of roughly $3.7 million in value, led by a $2.4 million sale by Chairman and CEO Ronald O'Hanley on October 20 and a $1.2 million sale by Chief Risk Officer Bradford Hu on October 26. Both trades were executed under pre-arranged 10b5-1 plans, which limits their signal value as expressions of discretionary conviction.

Among the closest peers, BNY fell 1.5% on the day and gained 1.3% on the week. NTRS dropped 2.2% on Friday and added 0.7% over the week. STT's own 1.2% weekly gain was broadly in line with the peer median of 1.6%, though Friday's 2.3% decline matched the sector's softer close. With the next earnings event scheduled for January 15, 2027, the short interest build, analyst target reductions, and insider selling under 10b5-1 plans are the data points to track between now and then.

Stocks in this article

See the live data behind this article on ORTEX.

Open STT on ORTEX →

How this article was generated

Generated
31 Oct 2026, 20:26
Data as of
31 Oct 2026, 20:25
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.